Title 16, Chapter 13, Section 27
( 16-13-27)
The controlled substances listed in this Code section are included
in Schedule III: (1) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances, included as
having a stimulant effect on the central nervous system, including
its salts, isomers (whether optical, position, or geometric), and
salts of such isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific
chemical designation: (A) Those compounds, mixtures, or preparations in dosage unit
forms containing any stimulant substances which are listed as
excepted compounds by the State Board of Pharmacy pursuant to
this article, and any other drug of quantitative composition so
excepted or which is the same except that it contains a lesser
quantity of controlled substances; (B) Benzphetamine; (C) Chlorphentermine; (D) Clortermine; (E) Phendimetrazine; (2) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances included as
having a depressant effect on the central nervous system: (A) Any compound, mixture, or preparation containing
amobarbital, secobarbital, pentobarbital, or any salts thereof
and one or more active medicinal ingredients which are not
listed in any schedule; (B) Any suppository dosage form containing amobarbital,
secobarbital, pentobarbital, or any salt of any of these drugs
and approved by the State Board of Pharmacy for marketing only
as a suppository; (C) Any substance which contains any quantity of a derivative of
barbituric acid or any salt thereof; (D) Chlorhexadol; (E) Reserved; (F) Lysergic acid; (G) Lysergic acid amide; (H) Methyprylon; (I) Sulfondiethylmethane; (J) Sulfonethylmethane;
(K) Sulfonmethane; (L) Tiletamine/Zolozepam (Telazol); (3) Nalorphine; (4) Unless specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation
containing limited quantities of the following narcotic drugs, or
any salts thereof: (A) Not more than 1.8 grams of codeine, or any of its salts, per
100 milliliters or not more than 90 milligrams per dosage unit,
with an equal or greater quantity of an isoquinoline alkaloid of
opium; (B) Not more than 1.8 grams of codeine, or any of its salts, per
100 milliliters or not more than 90 milligrams per dosage unit,
with one or more active, nonnarcotic ingredients in recognized
therapeutic amounts; (C) Not more than 300 milligrams of dihydrocodeinone
(hydrocodone), or any of its salts, per 100 milliliters or not
more than 15 milligrams per dosage unit, with a fourfold or
greater quantity of an isoquinoline alkaloid of opium; (D) Not more than 300 milligrams of dihydrocodeinone
(hydrocodone), or any of its salts, per 100 milliliters or not
more than 15 milligrams per dosage unit, with one or more
active, nonnarcotic ingredients in recognized therapeutic
amounts; (E) Not more than 1.8 grams of dihydrocodeine, or any of its
salts, per 100 milliliters or not more than 90 milligrams per
dosage unit, with one or more active, nonnarcotic ingredients in
recognized therapeutic amounts; (F) Not more than 300 milligrams of ethylmorphine, or any of its
salts, per 100 milliliters or not more than 15 milligrams per
dosage unit, with one or more active, nonnarcotic ingredients in
recognized therapeutic amounts; (G) Not more than 500 milligrams of opium per 100 milliliters or
per 100 grams, or not more than 25 milligrams per dosage unit,
with one or more active, nonnarcotic ingredients in recognized
therapeutic amounts; (H) Not more than 50 milligrams of morphine, or any of its
salts, per 100 milliliters or per 100 grams with one or more
active, nonnarcotic ingredients in recognized therapeutic
amounts; (5) The State Board of Pharmacy may except by rule any compound,
mixture, or preparation containing any stimulant or depressant
substance listed in paragraphs (1) and (2) of this Code section
from the application of all or any part of this article if the
compound, mixture, or preparation contains one or more active,
medicinal ingredients not having a stimulant or depressant effect
on the central nervous system, and if the admixtures are included
therein in combinations, quantity, proportion, or concentration
that vitiate the potential for abuse of the substances which have
a stimulant or depressant effect on the central nervous system; (6) Any anabolic steroid or any salt, ester, or isomer of a drug
or substance described or listed in this paragraph, if that salt,
ester, or isomer promotes muscle growth. Such term does not
include an anabolic steroid which is expressly intended for
administration through implants to cattle or other nonhuman
species and which has been approved by the secretary of health and
human services for such administration: (A) Boldenone; (B) Chlorotestosterone; (C) Clostebol; (D) Dehydrochlormethyltestosterone; (E) Dihydrotestosterone; (F) Drostanolone; (G) Ethylestrenol; (H) Fluoxymesterone; (I) Formebolone; (J) Mesterolone; (K) Methandienone; (L) Methandranone; (M) Methandriol; (N) Methandrostenolone; (O) Methenolone; (P) Methyltestosterone; (Q) Mibolerone; (R) Nandrolone; (S) Norethandrolone; (T) Oxandrolone; (U) Oxymesterone; (V) Oxymetholone; (W) Stanolone; (X) Stanozolol; (Y) Testolactone;
(Z) Testosterone; (AA) Trenbolone; (7) Ketamine; (8) Dronabinol (synthetic) in sesame oil and encapsulated in a
U.S. Food and Drug Administration approved drug product also known
as Marinol. |